Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2022 Jan 20;82(2):420-434.e6.
doi: 10.1016/j.molcel.2021.11.019. Epub 2021 Dec 23.

RNA circles with minimized immunogenicity as potent PKR inhibitors

Affiliations
Free article
Comparative Study

RNA circles with minimized immunogenicity as potent PKR inhibitors

Chu-Xiao Liu et al. Mol Cell. .
Free article

Abstract

Exon back-splicing-generated circular RNAs, as a group, can suppress double-stranded RNA (dsRNA)-activated protein kinase R (PKR) in cells. We have sought to synthesize immunogenicity-free, short dsRNA-containing RNA circles as PKR inhibitors. Here, we report that RNA circles synthesized by permuted self-splicing thymidylate synthase (td) introns from T4 bacteriophage or by Anabaena pre-tRNA group I intron could induce an immune response. Autocatalytic splicing introduces ∼74 nt td or ∼186 nt Anabaena extraneous fragments that can distort the folding status of original circular RNAs or form structures themselves to provoke innate immune responses. In contrast, synthesized RNA circles produced by T4 RNA ligase without extraneous fragments exhibit minimized immunogenicity. Importantly, directly ligated circular RNAs that form short dsRNA regions efficiently suppress PKR activation 103- to 106-fold higher than reported chemical compounds C16 and 2-AP, highlighting the future use of circular RNAs as potent inhibitors for diseases related to PKR overreaction.

Keywords: PKR; PKR inhibitor; T4 RNA ligase; circular RNA; circular RNA structure; dsRNA; group I intron; immune response; permuted Anabaena pre-tRNA group I intron; phage T4 thymidylate synthase gene.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests L.-L.C., C.-X.L., S.-K.G., and Y.-F.X. are named as inventors on patents related to circular RNA held by the CAS CEMCS. L.-L.C. is a member of the Molecular Cell advisory board.

Publication types

MeSH terms